T. Rowe Price Associates’s Johnson & Johnson JNJ Stock Holding History

T. Rowe Price Associates’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.03B	Buy	16,491,133 +4,067,247	+33%	+$947M	0.47%	32
2025 Q4	$2.57B	Buy	12,423,886 +3,655,754	+42%	+$723M	0.28%	67
2025 Q3	$1.63B	Buy	8,768,132 +390,599	+5%	+$66.9M	0.17%	106
2025 Q2	$1.28B	Sell	8,377,533 -1,728,540	-17%	-$266M	0.15%	138
2025 Q1	$1.68B	Sell	10,106,073 -6,177,098	-38%	-$967M	0.21%	92
2024 Q4	$2.35B	Sell	16,283,171 -8,877,281	-35%	-$1.38B	0.27%	66
2024 Q3	$4.08B	Buy	25,160,452 +251,257	+1%	+$40M	0.47%	38
2024 Q2	$3.64B	Buy	24,909,195 +3,074,836	+14%	+$457M	0.44%	41
2024 Q1	$3.45B	Buy	21,834,359 +3,139,499	+17%	+$500M	0.42%	44
2023 Q4	$2.93B	Buy	18,694,860 +232,738	+1%	+$35.7M	0.39%	47
2023 Q3	$2.88B	Sell	18,462,122 -9,453,413	-34%	-$1.56B	0.42%	45
2023 Q2	$4.62B	Buy	27,915,535 +1,081,734	+4%	+$175M	0.64%	24
2023 Q1	$4.16B	Sell	26,833,801 -2,443,973	-8%	-$395M	0.62%	28
2022 Q4	$5.17B	Buy	29,277,774 +3,849,148	+15%	+$665M	0.83%	18
2022 Q3	$4.15B	Buy	25,428,626 +805,831	+3%	+$136M	0.68%	26
2022 Q2	$4.37B	Buy	24,622,795 +3,912,430	+19%	+$697M	0.55%	28
2022 Q1	$3.67B	Buy	20,710,365 +6,215,994	+43%	+$1.06B	0.37%	47
2021 Q4	$2.48B	Sell	14,494,371 -683,126	-5%	-$112M	0.22%	92
2021 Q3	$2.45B	Buy	15,177,497 +16,836	+0.1%	+$2.87M	0.23%	97
2021 Q2	$2.5B	Sell	15,160,661 -201,387	-1%	-$33.3M	0.23%	94
2021 Q1	$2.52B	Sell	15,362,048 -1,874,856	-11%	-$303M	0.25%	85
2020 Q4	$2.71B	Buy	17,236,904 +692,267	+4%	+$102M	0.28%	73
2020 Q3	$2.46B	Sell	16,544,637 -541,853	-3%	-$80.2M	0.29%	71
2020 Q2	$2.4B	Sell	17,086,490 -1,914,763	-10%	-$279M	0.3%	66
2020 Q1	$2.49B	Sell	19,001,253 -2,146,605	-10%	-$305M	0.39%	50
2019 Q4	$3.08B	Buy	21,147,858 +2,884,267	+16%	+$391M	0.4%	49
2019 Q3	$2.36B	Sell	18,263,591 -2,528,122	-12%	-$333M	0.33%	64
2019 Q2	$2.9B	Buy	20,791,713 +2,204,757	+12%	+$305M	0.41%	53
2019 Q1	$2.6B	Buy	18,586,956 +1,734,666	+10%	+$232M	0.38%	60
2018 Q4	$2.17B	Sell	16,852,290 -959,285	-5%	-$134M	0.37%	60
2018 Q3	$2.46B	Buy	17,811,575 +1,058,612	+6%	+$141M	0.36%	59
2018 Q2	$2.03B	Sell	16,752,963 -3,952,064	-19%	-$493M	0.31%	71
2018 Q1	$2.65B	Buy	20,705,027 +1,424,096	+7%	+$192M	0.42%	51
2017 Q4	$2.69B	Buy	19,280,931 +221,038	+1%	+$30.8M	0.44%	45
2017 Q3	$2.48B	Sell	19,059,893 -2,611,213	-12%	-$346M	0.42%	49
2017 Q2	$2.87B	Sell	21,671,106 -249,303	-1%	-$31.8M	0.52%	31
2017 Q1	$2.73B	Buy	21,920,409 +4,228,037	+24%	+$505M	0.51%	33
2016 Q4	$2.04B	Buy	17,692,372 +394,814	+2%	+$45.6M	0.4%	53
2016 Q3	$2.04B	Buy	17,297,558 +171,695	+1%	+$20.8M	0.41%	54
2016 Q2	$2.08B	Sell	17,125,863 -1,031,336	-6%	-$117M	0.44%	44
2016 Q1	$1.96B	Sell	18,157,199 -1,123,860	-6%	-$116M	0.42%	46
2015 Q4	$1.98B	Sell	19,281,059 -1,100,417	-5%	-$111M	0.42%	50
2015 Q3	$1.9B	Buy	20,381,476 +1,444,505	+8%	+$140M	0.42%	49
2015 Q2	$1.85B	Sell	18,936,971 -20,412	-0.1%	-$2.04M	0.38%	58
2015 Q1	$1.91B	Sell	18,957,383 -599,335	-3%	-$60.9M	0.39%	55
2014 Q4	$2.05B	Sell	19,556,718 -6,187,667	-24%	-$652M	0.43%	49
2014 Q3	$2.74B	Sell	25,744,385 -260,089	-1%	-$27M	0.6%	28
2014 Q2	$2.72B	Buy	26,004,474 +51,819	+0.2%	+$5.24M	0.59%	27
2014 Q1	$2.55B	Buy	25,952,655 +167,719	+0.7%	+$15.5M	0.57%	28
2013 Q4	$2.36B	Sell	25,784,936 -250,357	-1%	-$23.1M	0.54%	31
2013 Q3	$2.26B	Sell	26,035,293 -997,229	-4%	-$89.5M	0.56%	29
2013 Q2	$2.32B	Buy	+27,032,522	New	+$2.29B	0.62%	22

Other funds holding JNJ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates's JNJ Position: Q1 2026 in Review

T. Rowe Price Associates increased its Johnson & Johnson (JNJ) stake by 33% in Q1 2026, buying an estimated $947M and bringing the position to 16,491,133 shares worth $4.03B. The position accounts for 0.47% of the portfolio, ranked #32.

T. Rowe Price Associates first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.17B in Q4 2022. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

T. Rowe Price Associates held 16,491,133 shares of Johnson & Johnson worth $4.03B as of Q1 2026.
T. Rowe Price Associates bought 4,067,247 Johnson & Johnson shares in Q1 2026, an estimated $947M.
Johnson & Johnson made up 0.47% of T. Rowe Price Associates's portfolio in Q1 2026, its #32 holding.
T. Rowe Price Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
T. Rowe Price Associates's Johnson & Johnson position peaked at $5.17B in Q4 2022.
4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.